Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
LIC MF Equity Savings Fund (G)
[Hybrid: Equity Savings]  
 
Fund Details
Fund Type Growth Launch Date 07-Mar-11
Corpus(Cr.) 39.00 Latest NAV 28.0072 As on 29-10-2026
Equity(%) 34.39 52 Week High 28.8304
Debt(%) 65.61 52 Week Low 26.6551
Others(%) 0.00 Exit Load For units in excess of 12% of the investment, 1% will be charged for redemption within 3 months
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark NIFTY Equity Savings TRI Broader Benchmark Hybrid 65 Debt+35 Equity Moderate Index
Fund Manager Siddharth Panjwani
 
Riskometer
Investors understand that their principal will be at Moderately High risk
 
Scheme Objective
The scheme seeks to provide regular income by investing in debt and money market instruments and using arbitrage and other derivative strategies. Also intends to generate long capital appreciation through unhedged exposure to equity and equity related instruments.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 64.24%
Top 10 Holdings 71.48%
Top 25 Holdings 87.05%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Cash 54.55
Debt MF 11.06
Banking & Financial 10.33
Automobile 8.54
Pharma & Biotech 7.4
Retail 5.71
Software & Services 4.45
Consumer Durables 4.21
Food Beverage & Tobacco 4.01
Industrial Products 2.63
Metals 2.35
Electricals 2.27
Finance & Investments 2.13
Construction 2.1
Chemicals 1.6
Agricultural & Farm Machinery 1.59
Miscellaneous 1.45
Aerospace & Defence 1.35
Telecom 1.23
Ferrous Metals 1.18
Healthcare 1.06
SERVICES 0.74
Derivatives -31.94
 
 
 
 
 
Portfolio Metrics
PB Ratio 4.37
PE Ratio 28.56
 
Top 25 Holdings
Holdings Net Asset(%)
Net Receivable / Payable 32.37
Treps 22.18
LIC MF LIQUID FUND-DR PLN-GR 9.73
Cipla Ltd. 2.66
State Bank Of India 2.23
Eternal Limited 2.01
Bajaj Auto Limited 1.79
APL Apollo Tubes Limited 1.78
Bank Of Baroda 1.74
Divis Laboratories Ltd. 1.68
Solar Industries India Limited 1.60
Ashok Leyland Ltd. 1.59
Torrent Pharmaceuticals Ltd. 1.59
Trent Ltd [Lakme Ltd] 1.53
Ajanta Pharma Ltd. 1.47
LG Electronics India Limited 1.47
Tata Consultancy Services Ltd. 1.43
UltraTech Cement Ltd 1.42
Radico Khaitan Ltd. 1.41
Hindalco Industries Ltd. 1.36
LIC MF MONEY MARKET FUND-DIRECT PLAN-GR 1.33
Kotak Mahindra Bank Ltd. 1.29
Sona BLW Precision Forgings Limited 1.29
FSN E-Commerce Ventures Limited 1.27
Bharti Airtel Ltd. 1.23

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-0.97% -1.25% 0.07% -1.34%
 
Broader Market Benchmark [Hybrid 65 Debt+35 Equity Moderate Index]
0.20% -2.45% -1.36% -3.54%
 
Scheme Benchmark [Hybrid 65 Debt+35 Equity Moderate Index]
0.20% -2.45% -1.36% -3.54%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
4.03% 7.22% 5.95% 6.26%
 
 
1.46% 6.59% 6.07% 7.84%
 
 
1.46% 6.59% 6.07% 7.84%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
LIC MF Equity Savings Fund (G) 7.27% 0.3984 5.7906% 41.6201 0.1254
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
LIC MF Equity Savings Fund (G) 3.0537% 0.0000 -1.6040 14.5111 1.4215
 
Back to Selection